Showing results (151-160 of 186) with videos related to
Sort By:
Pageof 19
Blood Advances|July 8, 2018
The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearanceAhmad H Mufti, Kenichi Ogiwara, Laura L Swystun, et al.Molecular Cell|February 20, 2016
Releasing Activity Disengages Cohesin's Smc3/Scc1 Interface in a Process Blocked by AcetylationFrederic Beckouët, Madhusudhan Srinivasan, Maurici Brunet Roig, et al.Toxicologic Pathology|June 23, 2026
New Modalities and Carcinogenicity AssessmentEmily K Meseck, Paul Batty, Tae-Won Kim, et al.Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.Research and Practice in Thrombosis and Haemostasis|February 3, 2025
Adeno-associated virus-based gene therapy for hemophilia-addressing the gapsWolfgang Miesbach, Paul Batty, Pratima Chowdary, et al.Blood|December 28, 2006
The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort studyPaula D James, Colleen Notley, Carol Hegadorn, et al.Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 20, 2024
UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adultsPratima Chowdary, Beatriz Duran, Paul Batty, et al.Journal of Thrombosis and Haemostasis : JTH|July 12, 2024
R1205H (Vicenza) causes conformational changes in the von Willebrand factor D'D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AIFerdows Atiq, Orla Rawley, Jamie M O'Sullivan, et al.The Journal of Clinical Investigation|August 21, 2018
The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicityLaura L Swystun, Jesse D Lai, Colleen Notley, et al.Pageof 19